Thelma
Analyst
Guggenheim
Equibles does not estimate personal net worth.
About Thelma
Thelma is recorded as Analyst at Guggenheim. Thelma has spoken on 1 earnings call across 1 company, most recently for Neumora Therapeutics, Inc. on March 30, 2026. The companies whose calls Thelma spoke on are classified in the Healthcare sector.
Thelma on recent calls
“So a clarification on the 215 TOC study. So have you received any specific guidance from the FDA on what would be required to clear the IND? Or are you proactively rerunning the studies based on your own assessment?”
Affiliation history
-
Guggenheim
Analyst
Transcript header (unverified)
Current